These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2052111)
1. [The use of corticosteroids in bronchopulmonary dysplasia]. Wesselink MW; van den Anker JN; Sauer PJ Ned Tijdschr Geneeskd; 1991 May; 135(21):943-6. PubMed ID: 2052111 [TBL] [Abstract][Full Text] [Related]
4. Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia. Kewitz G; Wudel S; Hopp H; Hopfenmüller W; Vogel M; Roots I J Perinat Med; 2008; 36(4):359-64. PubMed ID: 18598128 [TBL] [Abstract][Full Text] [Related]
5. [Effect of corticosteroids on lung function and the clinical course of bronchopulmonary dysplasia in premature infants with a birth weight below 1,500 g]. Hanssler L; Zhou C; Roll C; Wiesemann HG Klin Padiatr; 1994; 206(5):372-6. PubMed ID: 7799612 [TBL] [Abstract][Full Text] [Related]
6. Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia. Sobel DB; Philip AG Pediatrics; 1992 Oct; 90(4):529-33. PubMed ID: 1408504 [TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Alkalay AL; Pomerance JJ; Puri AR; Lin BJ; Vinstein AL; Neufeld ND; Klein AH Pediatrics; 1990 Aug; 86(2):204-10. PubMed ID: 2371095 [TBL] [Abstract][Full Text] [Related]
8. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Yoder BA; Harrison M; Clark RH Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192 [TBL] [Abstract][Full Text] [Related]
9. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study. DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552 [TBL] [Abstract][Full Text] [Related]
10. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone. Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597 [TBL] [Abstract][Full Text] [Related]
11. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland]. Kwinta P; Grudzień A; Pawlik D; Olechowski W; Lauterbach R; Pietrzyk JJ Przegl Lek; 2009; 66(1-2):14-20. PubMed ID: 19485250 [TBL] [Abstract][Full Text] [Related]
12. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan]. Bauer J; Beedgen B; Böhler T; Sontheimer D; Zilow EP; Linderkamp O Klin Padiatr; 1996; 208(2):56-60. PubMed ID: 8901183 [TBL] [Abstract][Full Text] [Related]
13. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia. McEvoy C; Bowling S; Williamson K; McGaw P; Durand M Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874 [TBL] [Abstract][Full Text] [Related]
16. Three-year experience with neonatal ventilation from a tertiary care hospital in Delhi. Singh M; Deorari AK; Paul VK; Mittal M; Shanker S; Munshi U; Jain Y Indian Pediatr; 1993 Jun; 30(6):783-9. PubMed ID: 8132260 [TBL] [Abstract][Full Text] [Related]
18. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Kazzi NJ; Brans YW; Poland RL Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226 [TBL] [Abstract][Full Text] [Related]
19. [Dexamethasone in the treatment of bronchopulmonary dysplasia]. Schrod L; Frauendienst-Egger G; Forgber I; von Stockhausen HB Pneumologie; 1991 Nov; 45(11):892-6. PubMed ID: 1762998 [TBL] [Abstract][Full Text] [Related]
20. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB; Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]